Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells Via the ROS/AMPK/mTOR Pathway

Overview

Journal Sci Rep

Specialty Science

Date 2016 Jun 22

PMID 27325206

Citations 45

Authors

Haiping Tang

Jin Li

Xiaohui Liu

Guihuai Wang

Minkui Luo

Haiteng Deng

Affiliations

Soon will be listed here.

Abstract

Glioblastoma is a fatal and incurable cancer with the hyper-activated mTOR pathway. HSP60, a major chaperone for maintenance of mitochondrial proteostasis, is highly expressed in glioblastoma patients. To understand the effects of HSP60 on glioblastoma tumorigenesis and progression, we characterized the HSP60-knockdowned glioblastoma cells and revealed that HSP60 silencing markedly suppressed cell proliferation and promoted cell to undergo the epithelial-mesenchymal transition (EMT). Proteomic analysis showed that ribosomal proteins were significantly downregulated whereas EMT-associated proteins were up-regulated in HSP60-knockdowned U87 cells as confirmed by a distinct enrichment pattern in newly synthesized proteins with azido-homoalanine labeling. Biochemical analysis revealed that HSP60 knockdown increased reactive oxygen species (ROS) production that led to AMPK activation, similarly to the complex I inhibitor rotenone-induced AMPK activation. Activated AMPK suppressed mTORC1 mediated S6K and 4EBP1 phosphorylation to decrease protein translation, which slowed down cell growth and proliferation. On the other hand, high levels of ROS in HSP60 knockdowned or rotenone-treated U87 cells contributed to EMT. These results indicate that HSP60 silencing deactivates the mTOR pathway to suppress glioblastoma progression, suggesting that HSP60 is a potential therapeutic target for glioblastoma treatment.

Citing Articles

Chaperones vs. oxidative stress in the pathobiology of ischemic stroke.

Soldatov V, Venediktov A, Belykh A, Piavchenko G, Naimzada M, Ogneva N Front Mol Neurosci. 2024; 17:1513084.

PMID: 39723236 PMC: 11668803. DOI: 10.3389/fnmol.2024.1513084.

The prohibitin ligand IN44 decreases Porphyromonas gingivalis mediated inflammation.

Stutz C, Gegout P, Bloch C, Ozcelik H, Anton N, Tabti R BMC Oral Health. 2024; 24(1):1534.

PMID: 39709363 PMC: 11662793. DOI: 10.1186/s12903-024-05209-2.

Mitochondrial unfolded protein response-dependent β-catenin signaling promotes neuroendocrine prostate cancer.

Woytash J, Kumar R, Chaudhary A, Donnelly C, Wojtulski A, Bethu M Oncogene. 2024; .

PMID: 39690273 DOI: 10.1038/s41388-024-03261-4.

HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling.

Zhang Y, Pan R, Li K, Cheang L, Zhao J, Zhong Z Int J Biol Sci. 2024; 20(13):5162-5190.

PMID: 39430254 PMC: 11489178. DOI: 10.7150/ijbs.100015.

Endurance exercise-induced histone methylation modification involved in skeletal muscle fiber type transition and mitochondrial biogenesis.

Li J, Zhang S, Li C, Zhang X, Shan Y, Zhang Z Sci Rep. 2024; 14(1):21154.

PMID: 39256490 PMC: 11387812. DOI: 10.1038/s41598-024-72088-6.

References

Stupp R, Hegi M, Mason W, van den Bent M, Taphoorn M, Janzer R . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7. View

Gu L, Chen Y, Wang Q, Li X, Mi K, Deng H . Functional Characterization of Sirtuin-like Protein in Mycobacterium smegmatis. J Proteome Res. 2015; 14(11):4441-9. DOI: 10.1021/acs.jproteome.5b00359. View

Hardie D, Pan D . Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans. 2002; 30(Pt 6):1064-70. DOI: 10.1042/bst0301064. View

Cappello F, Di Stefano A, DAnna S, Donner C, Zummo G . Immunopositivity of heat shock protein 60 as a biomarker of bronchial carcinogenesis. Lancet Oncol. 2005; 6(10):816. DOI: 10.1016/S1470-2045(05)70393-4. View

Grahame Hardie D . AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007; 8(10):774-85. DOI: 10.1038/nrm2249. View

Xu L, Chow K, Lim M, Li G . Current vaccine trials in glioblastoma: a review. J Immunol Res. 2014; 2014:796856. PMC: 3996322. DOI: 10.1155/2014/796856. View

Holz M, Ballif B, Gygi S, Blenis J . mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell. 2005; 123(4):569-80. DOI: 10.1016/j.cell.2005.10.024. View

Carroll J, Fearnley I, Skehel J, Shannon R, Hirst J, Walker J . Bovine complex I is a complex of 45 different subunits. J Biol Chem. 2006; 281(43):32724-7. DOI: 10.1074/jbc.M607135200. View

Sabharwal S, Schumacker P . Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?. Nat Rev Cancer. 2014; 14(11):709-21. PMC: 4657553. DOI: 10.1038/nrc3803. View

10.

Cappello F, Di Stefano A, David S, Rappa F, Anzalone R, La Rocca G . Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer. 2006; 107(10):2417-24. DOI: 10.1002/cncr.22265. View

11.

White G, Gianni S, Grossmann J, Jemth P, Fersht A, Daggett V . Simulation and experiment conspire to reveal cryptic intermediates and a slide from the nucleation-condensation to framework mechanism of folding. J Mol Biol. 2005; 350(4):757-75. DOI: 10.1016/j.jmb.2005.05.005. View

12.

Sharma L, Fang H, Liu J, Vartak R, Deng J, Bai Y . Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation. Hum Mol Genet. 2011; 20(23):4605-16. PMC: 3209831. DOI: 10.1093/hmg/ddr395. View

13.

Bukau B, Horwich A . The Hsp70 and Hsp60 chaperone machines. Cell. 1998; 92(3):351-66. DOI: 10.1016/s0092-8674(00)80928-9. View

14.

Krishan S, Richardson D, Sahni S . Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation. Mol Pharmacol. 2014; 87(3):363-77. DOI: 10.1124/mol.114.095810. View

15.

Roy L, Sahraei M, Subramani D, Besmer D, Nath S, Tinder T . MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene. 2010; 30(12):1449-59. PMC: 3063863. DOI: 10.1038/onc.2010.526. View

16.

Ghosh J, Dohi T, Kang B, Altieri D . Hsp60 regulation of tumor cell apoptosis. J Biol Chem. 2007; 283(8):5188-94. DOI: 10.1074/jbc.M705904200. View

17.

Gwinn D, Shackelford D, Egan D, Mihaylova M, Mery A, Vasquez D . AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008; 30(2):214-26. PMC: 2674027. DOI: 10.1016/j.molcel.2008.03.003. View

18.

Ruderman N, Carling D, Prentki M, Cacicedo J . AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. 2013; 123(7):2764-72. PMC: 3696539. DOI: 10.1172/JCI67227. View

19.

Steinberg G, Kemp B . AMPK in Health and Disease. Physiol Rev. 2009; 89(3):1025-78. DOI: 10.1152/physrev.00011.2008. View

20.

Gingras A, Gygi S, Raught B, Polakiewicz R, Abraham R, Hoekstra M . Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 1999; 13(11):1422-37. PMC: 316780. DOI: 10.1101/gad.13.11.1422. View